Skin cancer vaccine halved the risk of relapse in melanoma patients, research finds
Research demonstrates that an mRNA vaccine can successfully supplement treatment against cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Melanoma | Skin | Skin Cancer | Vaccines